The BioFuture™ Conference brings stakeholders together for a Transformational Healthcare Summit

The event highlighted cutting-edge technology and disruptive science for cutting-edge treatments

New York, November 17, 2022– (working wire) –BioFuture™produced by Demi Colton, and received more than 625 participants, more than 140 investors, and 80 exhibiting companies. Held at Lotte Mansion New York from November 7-9 and around the following week, the event brought together healthcare and biotech leaders, investors, industry stakeholders, and bleeding opponents who are reimagining therapies. Among the attendees were more than 30 journalists.

The 2022 program featured insights from senior executives in biotechnology, digital medicine, virtual reality, and healthcare across a broad range of areas of expertise. Highlights included the presence of New York City Mayor Eric Adam, as he affirmed his support for the city’s growing biosciences sector, and his influence on health-related issues. View Mayor Adam’s full opening remarks over here.

The conference also provided a platform for exclusive announcements from the companies presenting, including biotech startup Juvena Therapeutics Inc. which raised $41 million in new venture capital funding.

BioFuture™ featured over 100 speakers who examined the exciting convergence of rapidly evolving fields, including biopharmaceuticals, digital medicine, big data, artificial intelligence, virtual reality, healthcare systems, and more. “Big Think” plenary sessions, discussions and workshops explored the many factors that will shape and transform the future of therapies. List of all speakers available over herewith many notable leaders, including the following:

  • Rick Bright, Ph.D.former CEO, Institute for Epidemic Prevention, Rockefeller Foundation

  • Dr. Jennifer BoylePresident and CEO, MiNK Therapeutics

  • Phyllis Parkman Ferrell, global head of external engagement on Alzheimer’s disease and neurodegeneration at Eli Lilly & Company; Seconded Executive, Davos Alzheimer’s Collaborative

  • Walter Greenleaf, Ph.D.Neuroscientist and medical technology developer at Stanford University

  • Raphael RakowskiCEO, Chief Business Development Officer, Co-Founder, Medically Home

  • William A. Haseltine, Ph.D.President, ACCESS Health International

  • Leroy (Lee) Hood, MD, PhD.CEO and Founder, Phenome Health

  • Sanjay Mistry, Ph.D.Vice President, Venture Investments New Company Creation – Johnson & Johnson Innovation, JJDC, Inc.

  • Kush M Parmar, MD, PhD.Managing Partner, 5AM Ventures

  • Scott PenberthyDirector, Applied AI, Office of the CTO, Google

  • Mylin Yao, MDCo-founder and CEO, Univfy

“We were very pleased with the turnout for this year’s BioFuture™ Conference. Despite the current economic challenges, we were thrilled to see that some of our exhibiting companies have raised significant funding, underscoring our strong conviction that investors continue to be interested in this space.” Sarah Jane DemiFounder and CEO, Demi Colton. “We are all working together to foster joint collaboration and investment to develop innovative new therapies and ultimately improve healthcare outcomes for all,” says Demi.

As part of the virtual component of BioFuture, Demy-Colton provides all registrants with on-demand access to company presentations, audio recordings of all panels, and other content through January 31, 2023. Those interested in accessing program content can simply log into the HelloPartnering Partnership Platform with their registration information.

For more information, please visit the website Or follow us on Twitter at @employee.

About Demi Colton

Demy-Colton is a leading life sciences and digital health event organization at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its one-of-a-kind events facilitate networking on a global scale, including Biotech Showcase™, BioFuture™, Biotech CEO Summit Europe™, Biotech CEO Summit™ and Demy-Colton Virtual Salons. These events build networking communities that transcend geographic boundaries and establish ongoing, high-value relationships among top industry decision-makers, investors, and thought leaders, where investing, learning, and thoughtful conversations flourish. For more information visit

View source version on


Isabella Rodriguez
CG Life for BioFuture

Leave a Comment